Article Details
Retrieved on: 2022-04-27 11:37:02
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Based on DESTINY-Breast04 results where AstraZeneca and Daiichi Sankyo's ENHERTU demonstrated a significant improvement in both progression-free ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here